
|Podcasts|August 31, 2021
Healthy Bottom Line: COVID-19 and Marijuana Laws: Why Employee Drug Positivity is on the Rise in Healthcare
Author(s)Skylar Jeremias
Barry Sample, PhD, director of science and technology at Quest Diagnostics, discusses the rise in drug positivity rates among healthcare employees, the reasons behind the rise, and what can be done to combat them.
Advertisement
On this episode of Healthy Bottom Line, Barry Sample, PhD, director of science and technology at Quest Diagnostics, discusses the rise in drug positivity rates among healthcare professionals over the course of 2020 and the consequences of drug use among employees in healthcare settings. He also talks about the role that marijuana legislation has played a role in this increase as well as some solutions to reduce positivity rates.
Newsletter
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Chief Healthcare Executive
1
AI in health care: 26 leaders offer predictions for 2026
2
Cybersecurity is the missing link in America’s healthcare supply chain strategy | Viewpoint
3
The biggest healthcare gifts of 2025
4
Sustainable landscaping: A new perspective for hospitals | Viewpoint
5



































